ReviewLife (Basel, Switzerland)2025
The Emerging Clinical Relevance of Artificial Intelligence, Data Science, and Wearable Devices in Headache: A Narrative Review.
Review in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pediatric New Daily Persistent Headache: Integrating Novel Research Methods to Support and Delineate Evolving Clinical Phenotypes.Children (Basel, Switzerland) · 2026Article
- Validation of an AI-Based platform for structured diagnosis of headache disorders using ICHD-3 criteria.BMC neurology · 2025Article
- The Collapse of Brain Clearance: Glymphatic-Venous Failure, Aquaporin-4 Breakdown, and AI-Empowered Precision Neurotherapeutics in Intracranial Hypertension.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This narrative review introduces key concepts in artificial intelligence (AI), data science, and wearable devices aimed at headache clinicians and researchers. PubMed and IEEEXplore were searched to identify relevant studies, and these were reviewed systematically. We identified six primary research topics. First, the most common application of AI and data science is in the diagnosis of headache disorders, with reported accuracies of up to 90%. Second, AI and data science are used for predicting headache disease trajectories and forecasting attacks. Third, prediction of treatment effects and data-driven individualization of treatment prescription demonstrate promising results, with accuracies ranging from 40% to 83%. Fourth, AI and data science can uncover hidden information within headache datasets, offering clinicians deeper insights. Fifth, wearables, combined with AI and data science, can improve remote monitoring and migraine management. Lastly, user experience studies indicate strong interest from both clinicians and patients in adopting these technologies. The potential applications of AI, data science, and wearable device technologies in headache research are vast. However, many studies are small pilot studies, and models often suffer from poor performance, limited reporting, and lack of external validation, which impede generalizability and clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.